Table 3 Summary of Primary, Process, and Exploratory Outcomes, Indicators, and Sources
| Â | Indicator | Source |
|---|---|---|
Primary Outcomes | ||
 AYA retention in care | Follow-up visit within 3 months for newly enrolled AYA or those Lost to Follow Up (LTFU) (i.e. out of care for more than 3 months) | Clinic records |
Process Outcomes | ||
 HCW competency | Mean HCW scores per clinic | Faculty graded scores Exit interviews with trained HCWs |
 HCW satisfaction | Mean HCW score per clinic | HCW survey |
 AYA patient satisfaction | Mean AYA score per clinic | Tablet-based questionnaire |
Exploratory Outcomes | ||
 Adherence | Refills within 1 week of scheduled return visit; 95% or one or fewer missed doses in past month/dosing period | Clinic/pharmacy records |
 Viral suppression | Viral load (VL) <1000 copies per ml and a secondary analysis using VL <400 copies/ml | Clinic records |
 Linkage to APS services | STI/TB screening, Contraception uptake, mental health referral | Clinic records |
 Opportunistic Infections (OI) | Indication of at least one OI | Clinic records |
 Hospitalizations | Number of hospitalizations | Clinic records |
 AIDS defining illness | Diagnosis of at least one AIDS defining illness per national guidelines | Clinic record |
 Mortality | Death during follow up | Clinic records |
Cost effectiveness and Utility Outcomes | ||
 Cost effectiveness | Cost per additional HIV-positive AYA retained in care | Tablet-based questionnaire, published literature |
 Cost utility | Cost per life year saved and disability-adjusted life (DALY) averted | Tablet-based questionnaire, published literature |